TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21716986

Group type: EXPERIMENTAL
Intervention: Ormocer (Admira)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Nanofilled composite (Filtek Supreme)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Microhybrid composite (Tetric Ceram)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Nanoceramic composite (CeramX mono)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Unprepared positive control
Number of subjects: 84

Group type: COMPARATOR
Intervention: Unrestored negative control
Number of subjects: 84
Study: 19822631

Group type: EXPERIMENTAL
Intervention: Telemanagement
Number of subjects: 100

Group type: COMPARATOR
Intervention: Best available care (control)
Number of subjects: 100
Study: 17077434

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 327

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 327

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 327

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 327
Study: 15080855

Group type: EXPERIMENTAL
Intervention: SR 48692 (90 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SR 48692 (300 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SR 48692 (90 mg) and (300 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SR 48692
Number of subjects: 24
Study: 10662749

Group type: EXPERIMENTAL
Intervention: [(11)C]epinephrine (EPI)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: [(11)C]hydroxyephedrine (HED)
Number of subjects: 17

Group type: COMPARATOR
Intervention: EPI
Number of subjects: 17

Group type: COMPARATOR
Intervention: HED
Number of subjects: 17
Study: 9313662

Group type: EXPERIMENTAL
Intervention: 130 mg free beta-sitosterol daily
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 8365079

Group type: EXPERIMENTAL
Intervention: Whey hydrolysate formula (WH)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Whey-predominant formula (WF)
Number of subjects: 45
Study: 2444962

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of lysine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 14
Study: 29505773

Group type: EXPERIMENTAL
Intervention: Copper intrauterine device
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Norethisterone enanthate
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Medroxyprogesterone acetate and ethinyl estradiol
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Levonorgestrel implant
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Etonogestrel implant
Number of subjects: 266

Group type: COMPARATOR
Intervention: Hormonal contraceptive methods (overall)
Number of subjects: 266
Study: 27055427

Group type: EXPERIMENTAL
Intervention: Aerosolized N-acetylcysteine (NAC), administered starting within 12 hours of mechanical ventilation, once every 8 hours until stopping mechanical ventilation.
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Aerosolized N-acetylcysteine (NAC)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Control group (no NAC treatment)
Number of subjects: 117
Study: 24361248

Group type: EXPERIMENTAL
Intervention: Amrubicin (40-45 mg/m² for ages 70-74; 40 mg/m² for ages ≥ 75) intravenously on days 1-3 every 3 weeks for 4-6 cycles
Number of subjects: 62

Group type: COMPARATOR
Intervention: Carboplatin (AUC 5 on day 1) and Etoposide (80 mg/m² on days 1-3) every 3 weeks for 4-6 cycles
Number of subjects: 62
Study: 22983988

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 245
Study: 19900054

Group type: EXPERIMENTAL
Intervention: Laparoscopic antireflux surgery (LARS) in Group I (2000)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Laparoscopic antireflux surgery (LARS) in Group II (1995-96)
Number of subjects: 236
Study: 18455086

Group type: EXPERIMENTAL
Intervention: Finasteride treatment
Number of subjects: 0
Study: 16387895

Group type: EXPERIMENTAL
Intervention: Carbohydrate-rich beverages
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (fasted patients)
Number of subjects: 30
Study: 15570922

Group type: EXPERIMENTAL
Intervention: Tailored CPT-11 + TS-1
Number of subjects: 0

Group type: COMPARATOR
Intervention: TS-1
Number of subjects: 0
Study: 10898337

Group type: COMPARATOR
Intervention: Samarium 153 lexidronam at 1.0 mCi/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Samarium 153 lexidronam at 0.5 mCi/kg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9311544

Group type: EXPERIMENTAL
Intervention: Manganese-exposed workers
Number of subjects: 35

Group type: COMPARATOR
Intervention: C
Number of subjects: 35
Study: 7688774

Group type: EXPERIMENTAL
Intervention: Capsaicin 0.025% cream
Number of subjects: 197

Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 197
Study: 3756312

Group type: EXPERIMENTAL
Intervention: Bestatin treatment (daily oral administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (irradiated patients who did not receive Bestatin)
Number of subjects: 0
Study: 31820219

Group type: EXPERIMENTAL
Intervention: Individual Placement and Support (IPS)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Traditional vocational rehabilitation
Number of subjects: 146
Study: 31099133

Group type: EXPERIMENTAL
Intervention: Promote Children's Growth and Development (PCGD) intervention for 14 weeks
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 144
Study: 28938325

Group type: EXPERIMENTAL
Intervention: Dexpanthenol-vitamin A (Nazalnem) ointment applied to silastic splints
Number of subjects: 60

Group type: COMPARATOR
Intervention: Vaseline applied to silastic splints (Control)
Number of subjects: 60
Study: 25874578

Group type: EXPERIMENTAL
Intervention: GEn 600 mg
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: GEn 1200 mg
Number of subjects: 671

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 671

Group type: EXPERIMENTAL
Intervention: GEn 600 mg and 1200 mg
Number of subjects: 671
Study: 23797810

Group type: EXPERIMENTAL
Intervention: Laminin‐411, laminin‐511, and laminin‐521
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrin α6β1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrin α6β1-deficient mice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (wild-type mice)
Number of subjects: 0
Study: 20820174

Group type: EXPERIMENTAL
Intervention: Weight-loss diet (WL)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Weight-loss diet plus resistance training (WL+RT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 34
Study: 19772448

Group type: EXPERIMENTAL
Intervention: Standard Options + AIR insulin
Number of subjects: 1021

Group type: COMPARATOR
Intervention: Standard Options
Number of subjects: 1021
Study: 17425817

Group type: EXPERIMENTAL
Intervention: Ondansetron 0.2 mg mL-1 with PCA morphine
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no ondansetron)
Number of subjects: 160
Study: 15251380

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 246

Group type: COMPARATOR
Intervention: No statin therapy
Number of subjects: 246
Study: 11735012

Group type: EXPERIMENTAL
Intervention: Nasogastric tubes (NTs)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Gastrostomy tubes (GTs)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study: 9408725

Group type: EXPERIMENTAL
Intervention: Experimental arm of randomized consent design
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard treatment arm
Number of subjects: 0
Study: 8488909

Group type: EXPERIMENTAL
Intervention: Cyclosporine G
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cyclosporine A
Number of subjects: 32
Study: 3732088

Group type: EXPERIMENTAL
Intervention: Potassium-conserving diuretic (amiloride)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Potassium-losing diuretic (chlorthalidone)
Number of subjects: 0
Study: 31058784

Group type: EXPERIMENTAL
Intervention: 5 cm H2O positive end-expiratory pressure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Standard therapy control
Number of subjects: 40
Study: 28159703

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 200

Group type: COMPARATOR
Intervention: HF self-management education (attention control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: CBT-I
Number of subjects: 200
Study: 25981329

Group type: EXPERIMENTAL
Intervention: Guided Internet-delivered CBT (ICBT)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Group-delivered CBT (GCBT)
Number of subjects: 48
Study: 23876624

Group type: EXPERIMENTAL
Intervention: Dynamic hip screw (DHS)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Medoff sliding plate (MSP)
Number of subjects: 163
Study: 21601197

Group type: EXPERIMENTAL
Intervention: GnRH agonist trigger
Number of subjects: 0

Group type: COMPARATOR
Intervention: hCG trigger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Addition of hCG to culture media
Number of subjects: 0
Study: 19751797

Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy (CBT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Waiting-list (WG)
Number of subjects: 45
Study: 16674762

Group type: EXPERIMENTAL
Intervention: 50 mg diclofenac potassium sachets
Number of subjects: 328

Group type: COMPARATOR
Intervention: 50 mg diclofenac potassium tablets
Number of subjects: 328

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 328

Group type: COMPARATOR
Intervention: Both sachets and tablets
Number of subjects: 328
Study: 12661911

Group type: EXPERIMENTAL
Intervention: Biofeedback intervention
Number of subjects: 905

Group type: EXPERIMENTAL
Intervention: Relaxation-assisted biofeedback
Number of subjects: 905

Group type: COMPARATOR
Intervention: Non-intervention controls
Number of subjects: 905

Group type: COMPARATOR
Intervention: Sham or non-specific behavioral intervention controls
Number of subjects: 905
Study: 10708941

Group type: EXPERIMENTAL
Intervention: Clinical trials (BNLI)
Number of subjects: 7819

Group type: COMPARATOR
Intervention: Population-based patients
Number of subjects: 7819

Group type: EXPERIMENTAL
Intervention: BNLI patients aged 65-74 years
Number of subjects: 7819

Group type: COMPARATOR
Intervention: Population-based patients aged 65-74 years
Number of subjects: 7819

Group type: COMPARATOR
Intervention: Both clinical trials and population-based data sets
Number of subjects: 7819

Group type: EXPERIMENTAL
Intervention: Late stage patients
Number of subjects: 7819
Study: 8791970

Group type: EXPERIMENTAL
Intervention: Cisapride, 20 mg t.d.s.
Number of subjects: 37
Study: 1363508

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CYC) with corticosteroids (CS) and plasma exchanges (PE)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Prednisone and PE
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Short-term steroid therapy and PE with anti-viral therapy
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Anti-viral agents and PE
Number of subjects: 182
Study: 6099915

Group type: EXPERIMENTAL
Intervention: 150 mg ranitidine at night
Number of subjects: 61

Group type: COMPARATOR
Intervention: 400 mg cimetidine at night
Number of subjects: 61
Study: 30276906

Group type: EXPERIMENTAL
Intervention: Cannabis Use (CU)
Number of subjects: 37071

Group type: EXPERIMENTAL
Intervention: Cannabis Use Disorder (CUD)
Number of subjects: 37071
Study: 29066271

Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ustekinumab
Number of subjects: 0
Study: 26617284

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 25499341

Group type: EXPERIMENTAL
Intervention: Intravenous fasudil (30 mg over 30 min)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Inhaled iloprost (5 μg)
Number of subjects: 50
Study: 22521630

Group type: EXPERIMENTAL
Intervention: Intramuscular botulinum toxin A
Number of subjects: 55

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 55
Study: 20053579

Group type: EXPERIMENTAL
Intervention: Fitscan-derived rigid gas permeable contact lens
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional (habitual) contact lens
Number of subjects: 30
Study: 18606035

Group type: EXPERIMENTAL
Intervention: Foster care intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Institutional care
Number of subjects: 0
Study: 15714898

Group type: COMPARATOR
Intervention: Dichotic listening tests (Fused condition)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Dichotic listening tests (Non-Fused condition)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Phonological working memory test
Number of subjects: 34

Group type: COMPARATOR
Intervention: Phonological processing abilities
Number of subjects: 34
Study: 11812750

Group type: EXPERIMENTAL
Intervention: NN2211 (10 microg/kg)
Number of subjects: 11
Study: 10382082

Group type: EXPERIMENTAL
Intervention: Levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms)
Number of subjects: 173
Study: 8682116

Group type: EXPERIMENTAL
Intervention: Combination therapy (atenolol + nifedipine)
Number of subjects: 682

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 682

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 682
Study: 1899852

Group type: EXPERIMENTAL
Intervention: Alpha-interferon (7.5 MU/m2 three times weekly for 3 months, then 5 MU/m2 for 3 months, and 2.5 MU/m2 for 6 months)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Gamma-interferon (2 MU/m2 for 6 months)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 30
Study: 6538131

Group type: EXPERIMENTAL
Intervention: Phototherapy (Goeckerman or PUVA)
Number of subjects: 7
Study: 30252057

Group type: EXPERIMENTAL
Intervention: 11β‐MNTDC (100, 200, 400, and 800 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 11β‐MNTDC (with food)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 11β‐MNTDC (200, 400, and 800 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29176264

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate 1560 mg/d
Number of subjects: 73

Group type: COMPARATOR
Intervention: Chondroitin sulfate 260 mg/d (low-dose group, control group)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Chondroitin sulfate
Number of subjects: 73
Study: 26422612

Group type: EXPERIMENTAL
Intervention: Plyometric training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Traditional strength training
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Combined training
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 23939595

Group type: EXPERIMENTAL
Intervention: CBT + IE
Number of subjects: 140

Group type: COMPARATOR
Intervention: CBT + distraction
Number of subjects: 140
Study: 22699094

Group type: EXPERIMENTAL
Intervention: Adolescent-reported communication in Miami
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Parent-reported communication in Miami
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Parent-reported communication in Los Angeles
Number of subjects: 302
Study: 19066934

Group type: EXPERIMENTAL
Intervention: Hypertrophy (H): 4 sets of 10 repetitions in the squat at 75% of 1RM (90 s rest periods)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Strength (S): 11 sets of three repetitions at 90% of 1RM (5 min rest periods)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Power (P): 8 sets of 6 repetitions of jump squats at 0% of 1RM (3 min rest periods)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Rest (R) condition
Number of subjects: 10
Study: 17909376

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid artery surgery
Number of subjects: 0
Study: 15094439

Group type: EXPERIMENTAL
Intervention: Radio-guided tumour excision after intratumoral injection of 99mTc-nanocolloid
Number of subjects: 65

Group type: COMPARATOR
Intervention: Wire-directed excision alone (group 2)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Radio-guided tumour excision
Number of subjects: 65
Study: 10980585

Group type: EXPERIMENTAL
Intervention: 50% VO2max exercise bout
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 75% VO2max exercise bout
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 32
Study: 9052605

Group type: EXPERIMENTAL
Intervention: Endovaginal ultrasound (weekly vaginal probe ultrasound scans)
Number of subjects: 92

Group type: COMPARATOR
Intervention: No vaginal sonography (standard expectant management)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Endovaginal ultrasound
Number of subjects: 92

Group type: COMPARATOR
Intervention: No vaginal sonography
Number of subjects: 92
Study: 8367670

Group type: EXPERIMENTAL
Intervention: IVER 400 plus DEC 1 mg.kg‐1 (12 patients)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: IVER 400 plus DEC 3 mg.kg‐1 (17 patients)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: IVER 400 plus DEC 6 mg.kg‐1 (10 patients)
Number of subjects: 49

Group type: COMPARATOR
Intervention: DEC 6 mg.kg‐1 alone (5 patients)
Number of subjects: 49

Group type: COMPARATOR
Intervention: IVER 400 alone (5 patients)
Number of subjects: 49
Study: 3523394

Group type: EXPERIMENTAL
Intervention: Relaxation training
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cognitive coping
Number of subjects: 42

Group type: COMPARATOR
Intervention: Non-specific placebo control
Number of subjects: 42
Study: 2738261

Group type: COMPARATOR
Intervention: Single pulse defibrillation
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sequential pulse defibrillation
Number of subjects: 16
Study: 29248992

Group type: EXPERIMENTAL
Intervention: Cephalosporin alone (CEPH)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Cephalosporin + aminoglycoside (CEPH + AG)
Number of subjects: 126
Study: 27845859

Group type: COMPARATOR
Intervention: 25-hydroxyvitamin D (25-OHD) levels in women with MetS (35.26 ± 1.61 nmol/l)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Correlation of 25-OHD levels with waist circumference (WC)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Correlation of 25-OHD levels with body mass index (BMI)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Correlation of 25-OHD levels with fat mass index (FMI)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Correlation of 25-OHD levels with impaired fasting glucose (IFG)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Percentage of body fat in women with insufficient 25-OHD (39.6%)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Percentage of body fat in women with deficit of 25-OHD (48.2%)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Average hand grip strength of participants (27.4 ± 4.7 kg)
Number of subjects: 101
Study: 25586212

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Venlafaxine-extended release
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: All medications
Number of subjects: 1008
Study: 23852365

Group type: EXPERIMENTAL
Intervention: Real rTMS (1 Hz, 600 pulses per session, 90% resting motor threshold)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study: 21565338

Group type: EXPERIMENTAL
Intervention: Laparoendoscopic single-site surgery (LESS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional multiaccess laparoscopy (LPS)
Number of subjects: 60
Study: 19300267

Group type: EXPERIMENTAL
Intervention: Etomidate-remifentanil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol-remifentanil
Number of subjects: 60
Study: 16790650

Group type: EXPERIMENTAL
Intervention: Levobupivacaine 0.125% and sufentanil 0.75 microg/mL with epinephrine 1:800,000
Number of subjects: 70

Group type: COMPARATOR
Intervention: Levobupivacaine 0.125% and sufentanil 0.75 microg/mL without epinephrine
Number of subjects: 70
Study: 15518616

Group type: EXPERIMENTAL
Intervention: Radial approach
Number of subjects: 377

Group type: COMPARATOR
Intervention: Femoral approach
Number of subjects: 377
Study: 11103159

Group type: EXPERIMENTAL
Intervention: Cephalosporin antibiotic
Number of subjects: 76

Group type: COMPARATOR
Intervention: Bag extraction of the dissected gallbladder
Number of subjects: 76
Study: 9396959

Group type: EXPERIMENTAL
Intervention: Sertraline or paroxetine (SSRIs) for 6 weeks
Number of subjects: 25
Study: 8403959

Group type: EXPERIMENTAL
Intervention: Norepinephrine (0.06 to 0.2 microgram/kg/min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Epinephrine (0.02 to 0.2 microgram/kg/min)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Dopamine (3 to 12 micrograms/kg/min)
Number of subjects: 21
Study: 3945711

Group type: EXPERIMENTAL
Intervention: Napping
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Resting
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control (watching a neutral videotape)
Number of subjects: 94
Study: 29760054

Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intranasal administration of oxytocin
Number of subjects: 0
Study: 27256094

Group type: EXPERIMENTAL
Intervention: Community-based intervention including booklets, education sessions, resistance bands, and local walking groups
Number of subjects: 600

Group type: COMPARATOR
Intervention: Standard and 1-time advice (control group)
Number of subjects: 600
Study: 25515179

Group type: EXPERIMENTAL
Intervention: SPOTLIGHT‐Virtual Audit Tool (S‐VAT)
Number of subjects: 128
Study: 22199246

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 20451523

Group type: EXPERIMENTAL
Intervention: Lesogaberan (65 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 18564348

Group type: EXPERIMENTAL
Intervention: 500 mcg alprostadil cream
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 700 mcg alprostadil cream
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: 900 mcg alprostadil cream
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo cream
Number of subjects: 400